Alejandro Sanz‐Bravo

634 total citations
13 papers, 487 citations indexed

About

Alejandro Sanz‐Bravo is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Alejandro Sanz‐Bravo has authored 13 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Alejandro Sanz‐Bravo's work include Spondyloarthritis Studies and Treatments (7 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and vaccines and immunoinformatics approaches (2 papers). Alejandro Sanz‐Bravo is often cited by papers focused on Spondyloarthritis Studies and Treatments (7 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and vaccines and immunoinformatics approaches (2 papers). Alejandro Sanz‐Bravo collaborates with scholars based in Spain, Israel and Chile. Alejandro Sanz‐Bravo's co-authors include José A. Łópez de Castro, Adrian Martín‐Esteban, Carlos Alvarez‐Navarro, Pablo Guasp, Arie Admon, Eilon Barnea, Begoña Galocha, Marina S. Mazariegos, José Luís López-Campos and Hedda Wardemann and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alejandro Sanz‐Bravo

13 papers receiving 478 citations

Peers

Alejandro Sanz‐Bravo
Alejandro Sanz‐Bravo
Citations per year, relative to Alejandro Sanz‐Bravo Alejandro Sanz‐Bravo (= 1×) peers Laura Pattacini

Countries citing papers authored by Alejandro Sanz‐Bravo

Since Specialization
Citations

This map shows the geographic impact of Alejandro Sanz‐Bravo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Sanz‐Bravo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Sanz‐Bravo more than expected).

Fields of papers citing papers by Alejandro Sanz‐Bravo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Sanz‐Bravo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Sanz‐Bravo. The network helps show where Alejandro Sanz‐Bravo may publish in the future.

Co-authorship network of co-authors of Alejandro Sanz‐Bravo

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Sanz‐Bravo. A scholar is included among the top collaborators of Alejandro Sanz‐Bravo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Sanz‐Bravo. Alejandro Sanz‐Bravo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Honrubia, José M., Francisco J. Gutierrez-Alvarez, Alejandro Sanz‐Bravo, et al.. (2023). SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators. mBio. 14(1). e0313622–e0313622. 14 indexed citations
2.
Enjuanes, Luis, Isabel Sola, Sonia Zúñiga, et al.. (2022). Nature of viruses and pandemics: Coronaviruses. SHILAP Revista de lepidopterología. 3. 151–158. 5 indexed citations
3.
Gutierrez-Alvarez, Francisco J., José M. Honrubia, Alejandro Sanz‐Bravo, et al.. (2021). Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice. Proceedings of the National Academy of Sciences. 118(43). 12 indexed citations
4.
Delgado, Pilar, Christian E. Busse, Alejandro Sanz‐Bravo, et al.. (2020). ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies. Nature. 589(7841). 287–292. 88 indexed citations
5.
Sanz‐Bravo, Alejandro, Carlos Alvarez‐Navarro, Adrian Martín‐Esteban, et al.. (2018). Ranking the Contribution of Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Polymorphisms to Shaping the HLA-B*27 Peptidome. Molecular & Cellular Proteomics. 17(7). 1308–1323. 23 indexed citations
6.
Sanz‐Bravo, Alejandro, Adrian Martín‐Esteban, Jonas J. W. Kuiper, et al.. (2018). Allele-specific Alterations in the Peptidome Underlie the Joint Association of HLA-A*29:02 and Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) with Birdshot Chorioretinopathy. Molecular & Cellular Proteomics. 17(8). 1564–1577. 16 indexed citations
7.
Martín‐Esteban, Adrian, Alejandro Sanz‐Bravo, Pablo Guasp, et al.. (2017). Separate effects of the ankylosing spondylitis associated ERAP1 and ERAP2 aminopeptidases determine the influence of their combined phenotype on the HLA-B*27 peptidome. Journal of Autoimmunity. 79. 28–38. 49 indexed citations
8.
Castro, José A. Łópez de, et al.. (2016). Molecular and pathogenic effects of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in MHC-I-associated inflammatory disorders: Towards a unifying view. Molecular Immunology. 77. 193–204. 81 indexed citations
9.
Sanz‐Bravo, Alejandro, Carlos Alvarez‐Navarro, Eilon Barnea, et al.. (2014). Peptide Handling by HLA-B27 Subtypes Influences Their Biological Behavior, Association with Ankylosing Spondylitis and Susceptibility to Endoplasmic Reticulum Aminopeptidase 1 (ERAP1). Molecular & Cellular Proteomics. 13(12). 3367–3380. 36 indexed citations
10.
Sanz‐Bravo, Alejandro, José Luís López-Campos, Marina S. Mazariegos, & José A. Łópez de Castro. (2014). Dominant Role of the ERAP1 Polymorphism R528K in Shaping the HLA–B27 Peptidome Through Differential Processing Determined by Multiple Peptide Residues. Arthritis & Rheumatology. 67(3). 692–701. 35 indexed citations
11.
Martín‐Esteban, Adrian, et al.. (2013). Combined Effects of Ankylosing Spondylitis-associated ERAP1 Polymorphisms Outside the Catalytic and Peptide-binding Sites on the Processing of Natural HLA-B27 Ligands. Journal of Biological Chemistry. 289(7). 3978–3990. 38 indexed citations
12.
Sanz‐Bravo, Alejandro, et al.. (2012). Functional Interaction of the Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 1 Polymorphism and HLA-B27 in Vivo. Molecular & Cellular Proteomics. 11(11). 1416–1429. 77 indexed citations
13.
Sanz‐Bravo, Alejandro, et al.. (2011). The Origin of Proteasome-inhibitor Resistant HLA Class I Peptidomes: a Study With HLA-A*68:01. Molecular & Cellular Proteomics. 11(1). M111.011486–M111.011486. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026